全文获取类型
收费全文 | 2268篇 |
免费 | 154篇 |
国内免费 | 15篇 |
专业分类
耳鼻咽喉 | 16篇 |
儿科学 | 101篇 |
妇产科学 | 56篇 |
基础医学 | 257篇 |
口腔科学 | 49篇 |
临床医学 | 200篇 |
内科学 | 468篇 |
皮肤病学 | 27篇 |
神经病学 | 210篇 |
特种医学 | 141篇 |
外科学 | 338篇 |
综合类 | 36篇 |
预防医学 | 122篇 |
眼科学 | 72篇 |
药学 | 138篇 |
中国医学 | 7篇 |
肿瘤学 | 199篇 |
出版年
2023年 | 19篇 |
2022年 | 39篇 |
2021年 | 47篇 |
2020年 | 24篇 |
2019年 | 36篇 |
2018年 | 47篇 |
2017年 | 30篇 |
2016年 | 47篇 |
2015年 | 48篇 |
2014年 | 55篇 |
2013年 | 85篇 |
2012年 | 110篇 |
2011年 | 118篇 |
2010年 | 98篇 |
2009年 | 94篇 |
2008年 | 100篇 |
2007年 | 111篇 |
2006年 | 113篇 |
2005年 | 112篇 |
2004年 | 89篇 |
2003年 | 88篇 |
2002年 | 70篇 |
2001年 | 54篇 |
2000年 | 60篇 |
1999年 | 62篇 |
1998年 | 43篇 |
1997年 | 46篇 |
1996年 | 46篇 |
1995年 | 42篇 |
1994年 | 30篇 |
1993年 | 23篇 |
1992年 | 35篇 |
1991年 | 35篇 |
1990年 | 33篇 |
1989年 | 46篇 |
1988年 | 44篇 |
1987年 | 39篇 |
1986年 | 26篇 |
1985年 | 30篇 |
1984年 | 23篇 |
1983年 | 15篇 |
1982年 | 11篇 |
1981年 | 14篇 |
1980年 | 16篇 |
1979年 | 15篇 |
1978年 | 6篇 |
1977年 | 8篇 |
1976年 | 7篇 |
1973年 | 10篇 |
1967年 | 5篇 |
排序方式: 共有2437条查询结果,搜索用时 0 毫秒
71.
Evolution of social organization: a reappraisal for primates by using phylogenetic methods. 总被引:7,自引:1,他引:7 下载免费PDF全文
A Di Fiore D Rendall 《Proceedings of the National Academy of Sciences of the United States of America》1994,91(21):9941-9945
For many animal taxa, the extent to which phylogeny can account for the form of species' social systems has seldom been investigated formally. A quantitative phylogenetic analysis of social systems in the order Primates reveals that social organization may be strongly conserved in some lineages, even in the face of considerable ecological variability. This result has important implications for efforts to understand the evolution of animal societies and for attempts to reconstruct the social organization of early humans. 相似文献
72.
Calabrò ML Fiore JR Favero A Lepera A Saracino A Angarano G Schulz TF Chieco-Bianchi L 《The Journal of infectious diseases》1999,179(6):1534-1537
Epidemiologic studies suggest that human herpesvirus 8 (HHV-8) may be sexually transmitted. To study the potential for HHV-8 transmission through cervicovaginal (CV) secretions, the presence of HHV-8 DNA was investigated by nested polymerase chain reaction in the cellular fraction of CV secretions from 36 human immunodeficiency virus type 1 (HIV-1)-seropositive and 29 HIV-1-seronegative women. The same patients were tested for antibodies to two defined HHV-8 antigens (latency-associated nuclear antigen and open-reading frame 65-encoded structural protein) and for HHV-8 DNA in their peripheral blood mononuclear cells (PBMC). The findings were compared with the rate of HHV-8 detection in semen samples of 20 HIV-1-infected men. HHV-8 DNA was detected in the CV samples from only 1 HHV-8-seropositive AIDS patient, in 3 PBMC samples (1/29 HIV-1-seronegative patients, 1/3 AIDS patients with Kaposi's sarcoma, and 1/19 AIDS patients), and in 1 of 20 semen samples. HHV-8 infection was more common in HIV-1-infected than uninfected women. Thus HHV-8 DNA is only rarely detectable in CV secretions and semen of HHV-8-infected individuals. 相似文献
73.
74.
75.
Breast cancer is the most common cause of cancer death in women in this country. Until recently, the traditional treatment has been radical surgery with or without radiation therapy for patients with primary breast cancer, and palliative endocrine therapy followed by chemotherapy for patients with advanced disease. These treatments have met with limited effectiveness in terms of eradicating the disease. Studies in the past decade have given cause for optimism for breast cancer patients. Adjuvant systemic therapy after local treatment appears promising for certain subsets of patients with primary breast cancer. The development of estrogen receptor assays has markedly changed our approach to the disease and improved patient care. Estrogen receptor is an important prognostic factor and is useful in planning appropriate therapy for patients with primary breast cancer as well as those with advanced disease. Further research is urgently needed to improve the dismal survival of certain women with this common malignancy. 相似文献
76.
77.
78.
79.
Fiore Manganelli Raffaele Dubbioso Rosa Iodice Antonietta Topa Andrea Dardis Cinzia Valeria Russo Lucia Ruggiero Stefano Tozza Alessandro Filla Lucio Santoro 《Journal of neurology》2014,261(4):804-808
Adult patients with Niemann-Pick disease type C (NPC) usually develop cognitive impairment progressing to dementia, whose pathophysiology remains still unclear. Noteworthy parallels exist in cognitive impairment and cellular pathology of NPC and Alzheimer’s disease (AD). In particular, alterations of cholinergic system, which represent one of the pathological hallmarks and contribute to cognitive deterioration in AD, have recently been demonstrated in a human brain autopsy and in an experimental model of NPC. This finding raised the issue that central cholinergic circuits dysfunction may contribute to pathophysiology of cognitive impairment in NPC as well, and prompted us to evaluate the cholinergic functional involvement in NPC patients by applying a neurophysiologic technique, named short-latency afferent inhibition (SAI). We describe clinical, biochemical, molecular and neuropsychological features, and SAI findings in three patients affected by NPC. Diagnosis of NPC was assessed by molecular analysis of the NPC1 gene in all patients. In two of them, biochemical analysis of intracellular accumulation of unesterified cholesterol was also performed. The main clinical features were cerebellar ataxia, vertical supranuclear gaze palsy and a variable degree of cognitive impairment ranging from only memory impairment to severe dementia. Electrophysiological evaluation revealed a reduced SAI in all three patients. Our SAI findings provide evidence of cholinergic dysfunction in patients with the adult form of NPC, supporting that cholinergic alterations may play a role in cognitive impairment in NPC, and strengthening the similarities between NPC and AD. 相似文献
80.
Sveva Di Franco Aniello Alfieri Stephen Petrou Giovanni Damiani Maria Beatrice Passavanti Maria Caterina Pace Sebastiano Leone Marco Fiore 《World Journal of Virology》2020,9(3):27-37
The pandemic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has garnered the attention of scientists worldwide in the search for an effective treatment while also focusing on vaccine development. Several drugs have been used for the management of coronavirus disease 2019 (COVID-19), which has affected many hospitals and health centers worldwide. Statistically significant results are lacking on the effectiveness of the experimented drugs in reducing COVID-19 morbidity or mortality, as there are very few published randomized clinical trials. Despite this, the literature offers some material for study and reflection. This opinion review attempts to address three burning questions on COVID-19 treatment options. (1) What kind of studies are currently published or ongoing in the treatment of patients with COVID-19? (2) What drugs are currently described in the literature as options of treatment for patients affected by the infection? And (3) Are there specific clinical manifestations related to COVID-19 that can be treated with a customized and targeted therapy? By answering these questions, we wish to create a summary of current COVID-19 treatments and the anti-COVID-19 treatments proposed in the recent clinical trials developed in the last 3 mo, and to describe examples of clinical manifestations of the SARS-CoV-2 infection with a cause-related treatment. 相似文献